MENU
+Compare
SUVPF
Stock ticker: OTC
AS OF
Aug 12 closing price
Price
$229.00
Change
+$20.50 (+9.83%)
Capitalization
14.52B

SUVPF stock forecast, quote, news & analysis

Sartorius AG is a leading provider of bioprocessing solutions... Show more

SUVPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for SUVPF with price predictions
Aug 14, 2025

SUVPF in -18.82% downward trend, falling for three consecutive days on August 01, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where SUVPF declined for three days, in of 8 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

SUVPF moved below its 50-day moving average on July 31, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for SUVPF crossed bearishly below the 50-day moving average on July 31, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where SUVPF's RSI Oscillator exited the oversold zone, of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 14, 2025. You may want to consider a long position or call options on SUVPF as a result. In of 46 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SUVPF just turned positive on August 14, 2025. Looking at past instances where SUVPF's MACD turned positive, the stock continued to rise in of 32 cases over the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. SUVPF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.079) is normal, around the industry mean (10.967). P/E Ratio (130.350) is within average values for comparable stocks, (62.104). Projected Growth (PEG Ratio) (0.939) is also within normal values, averaging (1.878). Dividend Yield (0.004) settles around the average of (0.016) among similar stocks. P/S Ratio (1.931) is also within normal values, averaging (83.814).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SUVPF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

A.I.Advisor
published Dividends

SUVPF paid dividends on March 31, 2021

Sartorius AG SUVPF Stock Dividends
А dividend of $0.71 per share was paid with a record date of March 31, 2021, and an ex-dividend date of March 29, 2021. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Intuitive Surgical (NASDAQ:ISRG), Align Technology (NASDAQ:ALGN).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 10.98B. The market cap for tickers in the group ranges from 246 to 172.16B. ISRG holds the highest valuation in this group at 172.16B. The lowest valued company is PEMTF at 246.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was 0%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was 4%. TRUMF experienced the highest price growth at 21%, while CUPR experienced the biggest fall at -86%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was -25%. For the same stocks of the Industry, the average monthly volume growth was 12% and the average quarterly volume growth was 24%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 66
Price Growth Rating: 60
SMR Rating: 81
Profit Risk Rating: 91
Seasonality Score: -21 (-100 ... +100)
View a ticker or compare two or three
SUVPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
Otto-Brenner-Strasse 20
Phone
+49 5513080
Employees
14614
Web
https://www.sartorius.com